Search Results - Kopp, R. Manneh

  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    2566 Cabazitaxel for metastatic castration-resistant prostate cancer (mCRPC) real data in real life

    2566 Cabazitaxel for metastatic castration-resistant prostate cancer (mCRPC) real data in real life by Manneh Kopp, R, Alonso Gordoa, T, Celiz, P, Sepúlveda, J.M, Grande, E, CastellanoGauna, D

    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Correlation of radiological and immunochemical parameters with clinical outcome in patients with recurrent glioblastoma treated with Bevacizumab

    Correlation of radiological and immunochemical parameters with clinical outcome in patients with recurrent glioblastoma treated with Bevacizumab by Manneh Kopp, R. A., Sepúlveda-Sánchez, J. M., Ruano, Y., Toldos, O., Pérez Núñez, A., Cantero, D., Hilario, A., Ramos, A., de Velasco, G., Sánchez-Gómez, P., Hernández-Laín, A.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    46P BASAL (PRE-TREATMENT) PET SCAN [MAXIMUM STANDARDIZED UPTAKE VALUES (SUVMAX)] AS A PROGNOSTIC FACTOR IN SMALL CELL LUNG CANCER PATIENTS WITH EXTENDED DISEASE

    46P BASAL (PRE-TREATMENT) PET SCAN [MAXIMUM STANDARDIZED UPTAKE VALUES (SUVMAX)] AS A PROGNOSTIC FACTOR IN SMALL CELL LUNG CANCER PATIENTS WITH EXTENDED DISEASE by Aix, S. Ponce, Kopp, R. Manneh, Rubio, L. Parrilla, Docampo, L. Iglesias, Solis, S. Ruiz, Nuñez, J.A, Martinez, T. Pascual

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: